Individuals with metabolic syndrome who were heterozygous for the FokI SNP had higher iPTH levels (a marker for induction of insulin secretion) and higher β cell secretion (HOMA β) than individuals without this polymorphism. This evidence concerns the gene INS and metabolic syndrome.